T. Rowe Price Investment Management, Inc.

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1897612 BALTIMORE, MD

Position in AGIO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$50,364,074

+$50,339,794 QoQ

Shares Held

1,488,740

+166799.1% QoQ

Ownership

2.50%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $11,176,949,825 across 48 Biotechnology names. AGIO ranks #30 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	5,193,324	$1,718,315,111
2	ASND	Ascendis Pharma A/S	6,162,042	$1,409,443,866
3	CYTK	Cytokinetics Inc	17,523,840	$1,154,996,294
4	APGE	Apogee Therapeutics, Inc.	10,300,984	$867,033,823
5	PCVX	Vaxcyte, Inc.	12,126,017	$704,642,847
6	DYN	Dyne Therapeutics, Inc.	30,785,801	$558,146,572
7	BNTX	BioNTech SE	5,856,073	$520,487,768
8	IONS	Ionis Pharmaceuticals Inc	6,159,027	$462,481,337

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$50,364,074	1,488,740	+166799.1%	Shares	Sole	2026-05-15
2025-12-31	$24,280	892	-99.9%	Shares	Sole	2026-02-19
2024-03-31	$27,152,147	928,596	-0.1%	Shares	Sole	2024-05-15
2023-12-31	$20,709,006	929,906	-0.0%	Shares	Sole	2024-02-14
2023-09-30	$23,018,762	930,051	0.0%	Shares	Sole	2023-11-14
2023-06-30	$26,339,044	930,051	-3.8%	Shares	Sole	2023-08-14
2023-03-31	$22,217,755	967,251	-1.2%	Shares	Sole	2023-05-15
2022-12-31	$27,493,493	979,113	-1.0%	Shares	Sole	2023-02-14
2022-09-30	$27,981,900	989,459	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.